SMETANA, Jan, Petr KUGLÍK, Henrieta GREŠLIKOVÁ, Renata KUPSKÁ, Pavel NĚMEC, Kristina BERÁNKOVÁ, Romana ZAORALOVÁ, Hana FILKOVÁ, Luděk POUR, Marta KREJČÍ, Lenka ZAHRADOVÁ, Michal HOLÁNEK, Zdeněk ADAM a Roman HÁJEK. Prognostic and predictive impact of cytogenetic changes in relapsed multiple myeloma patients treated with bortezomib or thalidomid based regiments: a Czech group experience. 2010. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{920576, author = {Smetana, Jan and Kuglík, Petr and Grešliková, Henrieta and Kupská, Renata and Němec, Pavel and Beránková, Kristina and Zaoralová, Romana and Filková, Hana and Pour, Luděk and Krejčí, Marta and Zahradová, Lenka and Holánek, Michal and Adam, Zdeněk and Hájek, Roman}, keywords = {Cancer Cytogenetics,multiple myeloma, FISH}, title = {Prognostic and predictive impact of cytogenetic changes in relapsed multiple myeloma patients treated with bortezomib or thalidomid based regiments: a Czech group experience}, url = {http://www.ashg.org/cgi-bin/2010/ashg10s?author=smetana&sort=ptimes&sbutton=Detail&absno=21887&sid=887393}, year = {2010} }
TY - CONF ID - 920576 AU - Smetana, Jan - Kuglík, Petr - Grešliková, Henrieta - Kupská, Renata - Němec, Pavel - Beránková, Kristina - Zaoralová, Romana - Filková, Hana - Pour, Luděk - Krejčí, Marta - Zahradová, Lenka - Holánek, Michal - Adam, Zdeněk - Hájek, Roman PY - 2010 TI - Prognostic and predictive impact of cytogenetic changes in relapsed multiple myeloma patients treated with bortezomib or thalidomid based regiments: a Czech group experience KW - Cancer Cytogenetics,multiple myeloma, FISH UR - http://www.ashg.org/cgi-bin/2010/ashg10s?author=smetana&sort=ptimes&sbutton=Detail&absno=21887&sid=887393 ER -
SMETANA, Jan, Petr KUGLÍK, Henrieta GREŠLIKOVÁ, Renata KUPSKÁ, Pavel NĚMEC, Kristina BERÁNKOVÁ, Romana ZAORALOVÁ, Hana FILKOVÁ, Luděk POUR, Marta KREJČÍ, Lenka ZAHRADOVÁ, Michal HOLÁNEK, Zdeněk ADAM a Roman HÁJEK. \textit{Prognostic and predictive impact of cytogenetic changes in relapsed multiple myeloma patients treated with bortezomib or thalidomid based regiments: a Czech group experience}. 2010.
|